Net revenue and net profit saw strong year-over-year growth in H1 2024, with robust gross and net margins. The group maintained a healthy capital structure, distributed significant dividends, and continued to expand its healthcare network across Indonesia.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.